DekaBank Deutsche Girozentrale’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.56M | Hold |
80,000
| – | – | ﹤0.01% | 789 |
|
2025
Q1 | $1.44M | Hold |
80,000
| – | – | ﹤0.01% | 783 |
|
2024
Q4 | $1.36M | Hold |
80,000
| – | – | ﹤0.01% | 815 |
|
2024
Q3 | $1.44M | Hold |
80,000
| – | – | ﹤0.01% | 827 |
|
2024
Q2 | $1.44M | Hold |
80,000
| – | – | ﹤0.01% | 819 |
|
2024
Q1 | $1.44M | Hold |
80,000
| – | – | ﹤0.01% | 811 |
|
2023
Q4 | $920K | Hold |
80,000
| – | – | ﹤0.01% | 916 |
|
2023
Q3 | $471K | Hold |
80,000
| – | – | ﹤0.01% | 1026 |
|
2023
Q2 | $602K | Buy |
80,000
+50,000
| +167% | +$376K | ﹤0.01% | 993 |
|
2023
Q1 | $200K | Hold |
30,000
| – | – | ﹤0.01% | 1178 |
|
2022
Q4 | $265K | Hold |
30,000
| – | – | ﹤0.01% | 1177 |
|
2022
Q3 | $291K | Buy |
30,000
+10,200
| +52% | +$98.9K | ﹤0.01% | 1159 |
|
2022
Q2 | $153K | Hold |
19,800
| – | – | ﹤0.01% | 1237 |
|
2022
Q1 | $183K | Buy |
19,800
+1,800
| +10% | +$16.6K | ﹤0.01% | 1224 |
|
2021
Q4 | $269K | Buy |
+18,000
| New | +$269K | ﹤0.01% | 1215 |
|